Clinical Trial Update: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) [Phase 3]

View source ↗

Summary

Phase 3 trial update on Tumor Treating Fields (TTFields) at 150 kHz used alongside standard therapies for stage IV non-small cell lung cancer following platinum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: NovoCure GmbH | Conditions: Nonsmall Cell Lung Cancer, NSCLC | Phase 3 | Status: COMPLETED | Results posted: 2026-03-18